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ong-Term Efficacy of Cryo Catheter
blation for the Treatment of Atrial Flutter
esults From a Repeat Electrophysiologic Study
nnibale S. Montenero, MD,* Nicola Bruno, MD,* Andrea Antonelli, MD,* Daniele Mangiameli, MD,*
uca Barbieri, MD,* Peter Andrew, MMEDSCI, PHD,*† Olive Murphy, MSC,‡ Stephen O’Connor, PHD,‡
rancesco Zumbo, MD*
ilan, Italy; and Kirkland, Canada
OBJECTIVES We investigated the long-term efficacy of cryo ablation for treatment of atrial flutter.
BACKGROUND To our knowledge, no study has assessed the long-term efficacy of cryo ablation by assessing
both symptom and conduction recurrence.
METHODS A total of 45 consecutive patients with symptomatic atrial flutter were ablated with a 7-F,
6-mm-tip, quadripolar cryo catheter (Freezor Xtra, CryoCath Technologies Inc., Kirkland,
Canada). Electrophysiologic studies (EPS) were performed with diagnostic catheters. Cryo
ablation was at 75°C for 4 min, beginning at the inferior rim of the coronary sinus os and
creating a posterior line to the Eustachian ridge. Safety, bi-directional isthmus block at
intervention, and recurrence at three, six, and nine months post procedure were assessed.
RESULTS There were no adverse events reported. All patients were free of discomfort on cryo energy
delivery. The acute success rate at intervention was 87%. Follow-up data from 39 acutely
successful patients showed 27 (69%) without conduction recurrence on repeat EPS at three
months, and none (0%) had symptom recurrence documented by Holter monitoring,
electrocardiogram, and/or patient diary records at three, six, and nine months follow-up.
CONCLUSIONS Our experience with a new 7-F, 6-mm-tip, quadripolar cryo catheter yielded a fairly high
success rate at intervention, an excellent safety profile, and a good chronic success rate in
terms of symptom recurrence. However, further monitoring is necessary to determine
whether all asymptomatic patients continue to remain free of symptoms, given the small pool
of patients demonstrated to have conduction recurrence. (J Am Coll Cardiol 2005;45:
ublished by Elsevier Inc. doi:10.1016/j.jacc.2004.10.059573–80) © 2005 by the American College of Cardiology Foundation
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sadiofrequency (RF) ablation of the isthmus between the
ricuspid annulus and the inferior vena cava is commonly
sed to treat atrial flutter (1). This well-established target is
nown as the cavotricuspid isthmus (CTI) (2,3). The
easibility of using a hand-held catheter to deliver cryo
nergy to successfully ablate the CTI was first demonstrated
y Dubuc et al. in a series of experiments in dogs (4), and
ore recently there has been an accumulation of clinical
xperience with cryo ablation catheters in the treatment of
atients with both common and atypical atrial flutter (5–8).
Our experience, as well as that of others, is that the focal
esions produced by cryo ablation are effective in creating
ermanent bi-directional isthmus block (5–7). Recurrence
ates after RF ablation treatment for atrial flutter are
etween 0% and 31% over follow-up periods ranging from
to 68 months (8–11). The wide variation in recurrence
ates reported by these studies may be due in part to
ifferent methods of recording recurrence—some studies
ave documented recurrence primarily by electrocardiogram
From the *Cardiology Department and Arrhythmia Center of Policlinico Multi-
edica, Sesto S.Giovanni, Milan, Italy; †Atlas Medical Science Writers Inc.,
ontreal, Canada; and ‡CryoCath Technologies Inc., Kirkland, Canada. Dr. Fred
orady acted as Guest Editor for this paper.r
Manuscript received August 3, 2004; revised manuscript received October 18,
004, accepted October 19, 2004.ECG) and/or patient diary records, whereas others have
erformed invasive repeat electrophysiologic study (EPS)
ost ablation. A recent study involving cryo ablation treat-
ent for atrial flutter reported a symptom recurrence rate of
1% over a mean follow-up period of approximately 18
onths (5). Although this study demonstrated the long-
erm efficacy of cryo ablation treatment for atrial flutter, the
ethod of recording recurrence did not involve a repeat
PS, and consequently some patients categorized as asymp-
omatic may have had conduction recurrence demonstrated
ith repeat EPS. Such patients are a potential reservoir of
ndividuals who could eventually become symptomatic.
The aim of this study was to document our experience
ith a new 7-F, 6-mm-tip, quadripolar cryo catheter in the
reatment of patients with atrial flutter. Apart from safety
nd acute efficacy data, we sought to assess long-term
fficacy by performing a follow-up assessment of arrhythmia
ecurrence using repeat EPS as well as ECG, patient diary
ecords, and Holter monitoring.
ETHODS
emographics. The study population consisted of 45 con-
ecutive patients with symptomatic atrial flutter who were
eferred to our institute to undergo ablation for recurrent
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Atrial Flutter and Cryo Ablation February 15, 2005:573–80trial flutter between May 2002 and May 2003. The local
thics committee approved the protocol, and patient in-
ormed consent was obtained from all patients before the
rocedure. All patients had previously been treated for atrial
utter with two or more drug regimens at the time of the
blation. No patient had previous RF ablation or cryo
blation. Eligibility for ablation required that all patients
ad at least two documented symptomatic episodes of atrial
utter recorded either by ECG or Holter monitoring. All
atients received an echocardiogram to ascertain the exis-
ence of cardiac pathology, underlying cardiac disease, and
o measure left ventricular ejection fraction (LVEF). Anti-
rrhythmic drugs were withdrawn in all patients at least one
eek before ablation, with the exception of amiodarone that
as withdrawn eight weeks before intervention. The anti-
nxiety drug diazepam was administered to a few patients at
he discretion of the investigator. Patients were not antico-
gulated as part of the ablation procedure. Three month
ollow-up data were available from 39 patients, all of whom
ere successfully ablated at intervention.
nd points. Bi-directional conduction block at interven-
ion was assessed by the following two steps: 1) Pacing the
trium at the coronary sinus (CS) immediately adjacent to
he line of block (e.g., CS os) and recording at the lateral
ree wall (AL1) (Fig. 1). If the resultant atrial activation on
he opposite side of the line of block at AL1 is late, this
ndicated that the wave of depolarization must proceed
round the entire right atrium in a counterclockwise direc-
ion to the opposite side of the line of block. 2) Pacing from
L1 on the lateral free wall and recording at the CS os.
his confirmed that the resultant atrial activation at the CS
s is late, indicating that the wave of depolarization must
roceed around the entire right atrium in a clockwise
irection to the opposite side of the line of block.
At three-month follow-up, a repeat EPS was performed
o determine whether conduction recurrence could be dem-
nstrated. Catheters were positioned as for the ablation
rocedure. Atrial flutter inducibility and bi-directional con-
uction were evaluated. The programmed atrial stimulation
nvolved a basic drive cycle length of 600 ms and a single
xtrastimulus at 400 ms with 20-ms decrements. If this was
neffective, a second extrastimulus at 300 ms with 20-ms
ecrements was delivered. Bi-directional block was assessed
y pacing from the CS os and AL1 (Fig. 1).
Symptom recurrence rate at three, six, and nine months
ost procedure was documented by Holter monitoring,
Abbreviations and Acronyms
CS  coronary sinus
CTI  cavotricuspid isthmus
ECG  electrocardiogram
EPS  electrophysiologic study
LVEF  left ventricular ejection fraction
RF  radiofrequencyCG, and/or patient diary records. Holter monitoring was Terformed on a monthly basis for all patients, and two
atients had an implantable loop recorder implanted that
as checked weekly.
Adverse events and patient reporting of discomfort with
ryo energy delivery were recorded.
atheters. DIAGNOSTIC. A 7-F, 24-pole catheter (Or-
iter, USCI-Bard Inc., Bellerica, Massachusetts) with alter-
ating 2-14-2-mm interelectrode distance was placed, via
he right femoral vein, into the trabeculated right atrium to
imultaneously record electrical activity in the right atrial
ree wall, the atrial roof, and the anterior septum. A 10-pole
atheter (USCI-Bard Inc.) was placed in the CS via the left
ubclavian vein for recording the left atrium and part of the
nfero-posterior atrial septum. A 10-pole catheter with
-mm inter-electrode spacing was inserted via the right
emoral vein and positioned along the atrial septum in the
is bundle region.
BLATION. In all cases, a commercially available 7-F de-
ectable, quadripolar catheter with a 6-mm-tip electrode
Freezor Xtra, CryoCath Technologies Inc., Kirkland,
anada) available with a large reach was used (7).
lectrogram recordings. Bipolar intracardiac electrograms
ltered between 30 and 250 Hz were digitally recorded and
tored on a Lab System 3.57 (USCI-Bard Inc., Bellerica,
assachusetts). A three-lead surface ECG was used simul-
aneously. Digital calipers were used to calculate atrial
ctivation times in sinus rhythm and the atrial flutter cycle
ength (F-F intervals).
aseline EPS. A baseline EPS was done with all patients
n sinus rhythm and a non-sedated state. All patients
eceived local anesthesia with lidocaine. Pacing was deliv-
red via the Orbiter catheter placed close to the right atrial
uricula at twice the diastolic threshold with a 2-ms pulse
idth.
nduction of atrial flutter. During the baseline EPS,
ustained or non-sustained atrial flutter was induced by
rogrammed atrial stimulation to identify patterns of acti-
ation consistent with atypical forms of atrial flutter or rapid
trial tachycardia. It was possible to induce atrial flutter in
pproximately 90% of our patient group. Thereafter, atrial
acing at a cycle length 20% shorter than the atrial flutter
ycle length was used to perform concealed entrainment and
erminate atrial flutter. In the remaining 10% of patients in
hom atrial flutter could not be induced, we moved directly
o isthmus site evaluation and subsequent ablation; all
atients received ablation in the CS os with pacing after
onversion to sinus rhythm to assess conduction block
cross the isthmus.
nitial positioning of the ablation catheter. In all proce-
ures, the ablation catheter was initially placed under
uoroscopic guidance (45° left anterior oblique and right
nterior oblique projections) at the posterior isthmus close
o the CS os (Fig. 1). The ablation catheter was positioned
o ensure stability plus good electrode-endocardium contact.
his was confirmed by stable intracardiac electrograms.
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February 15, 2005:573–80 Atrial Flutter and Cryo Ablationetermining the target site for ablation. Previous ablation
xperience suggested that specific electrogram characteristics
ifferentiated successful from unsuccessful target sites (7).
ssentially, a successful target site exhibited a time to effect,
efined as the length of time required to observe an electro-
hysiologic change in the area being ablated, of approximately
0 s after 60 s of cryo energy delivery at 75°C. Hence, after
nitial fluoroscopic positioning of the ablation catheter at the
igure 1. Fluorographic images of anatomic placement of the new 7-F, 6-
nterior oblique view of right atrium. (Bottom) Right anterior oblique view
all electrode; CS 1  distal coronary sinus electrode; CS os  proximal e
lectrode.osterior isthmus close to the CS os, all subsequent catheter cepositioning was done with the aid of anatomic (fluoroscopic)
nd electrophysiologic (EPS) guidance. Having anatomically
ositioned the ablation catheter at a site, a cryo test (e.g., cryo
nergy delivery for up to 60 s at 75°C) was performed in an
ttempt to create an electrophysiologic change (e.g., transient
eversible conduction block); 60 s of cryo energy delivery at
75°C was used on the basis of investigator experience that
elay of conduction at the isthmus appears at 60 s of
ip, quadripolar cryo catheter for the treatment of atrial flutter. (Top) Left
ht atrium. ABI  cryo ablation catheter; AL 1  anterolateral right atrial
de at coronary sinus os; HIS  His bundle catheter; MS 12  midseptalmm-t
of rig
lectroryoapplication (7). Pacing was performed during cryo testing
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Atrial Flutter and Cryo Ablation February 15, 2005:573–80o identify bi-directional block. Generally, successful cryo
esting prolonged conduction by 30 to 40 ms. If prolongation
f conduction was not achieved, the cryo test was halted, the
arget tissue was allowed to re-warm and regain its electro-
hysiologic properties, and the ablation catheter was slightly
epositioned. This ability to create transient reversible conduc-
ion block using cryo energy has been discussed elsewhere
nder the guise of cryo or ice mapping (12).
blation protocol to create permanent bi-directional
lock. When an electrogram showed that a cryo test at a
pecific target site caused the desired electrophysiologic
erturbation (e.g., complete bi-directional block of conduc-
ion over the CTI), cryo energy delivery to this target was
aintained for 4 min at 75°C. This created a permanent
ryo lesion. Some patients exhibited flutter that was termi-
ated during the ablation procedure. However, flutter in-
erruption per se did not mean successful ablation; recovery
f sinus rhythm was necessary to pace the heart from the CS
s to assess conduction across the isthmus in these (and
ther) patients. Double potentials were demonstrated at the
nd of the ablation (Fig. 2). Bi-directional conduction block
efined the end point of the ablation procedure. Assessment
f whether bi-directional block was achieved was by pacing
Figure 2. Demonstration of double potentials during the ablatihe atrium from the CS os and sensing on the lateral wall, end vice-versa as described earlier. Once bi-directional
lock was achieved, no additional cryoapplications were
elivered to complete a lesion line across the CTI. Isopro-
erenol was not used to test completeness of the conduction
lock after the ablation, and a pacing cycle length of 600 and
00 ms was used to assess conduction block; current levels
ere 15 mA amplitude for 5 ms duration. A 30-min wait
eriod occurred between the initial successful ablation and
ubsequent re-testing to ensure bi-directional block re-
ained; a 30-min wait period was selected based on
nvestigator experience with ablation procedures for atrial
utter as well as evidence from published data (3). Patients
ere asked to report any discomfort they felt throughout the
blation procedure; their comments were recorded on a
atient chart.
hree-, six-, and nine-month follow-up. All patients
ept a diary record of symptoms experienced after the
blation procedure. These records were collected at our
ut-patient clinic every month. A general cardiovascular
heck-up and ECG were also performed as part of the
linical follow-up. A follow-up invasive repeat EPS was
erformed on all consenting patients at approximately three
onths post ablation; bi-directional block was assessed in
ocedure. Arrows in the trace demarcate the double potentials.xactly the same way it was at intervention. The same
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February 15, 2005:573–80 Atrial Flutter and Cryo Ablationnduction protocol was used for the repeat EPS as was
reviously used in the ablation procedure; a second ablation
as scheduled for any patient who had conduction recur-
ence demonstrated on repeat EPS, and an identical induc-
ion protocol was employed as previously described.
tatistical analysis. STATISTICA version 6.0 (StatSoft
nc., Tulsa, Oklahoma) was used for all statistical analysis.
n unpaired t test was generally used to compare the
umber of cryo tests performed, ablations delivered, and
ryoapplication times between acute success patients versus
cute failure patients, as well as for those conduction
ecurrent patients versus non-conduction recurrent patients.
hen normality and equal variance analyses failed, a
ann-Whitney rank sum test was used instead of an
npaired t test. The significance level was set at p  0.05.
ESULTS
emographics. The study population consisted of 45 pa-
ients with symptomatic atrial flutter; 43 patients had
ommon atrial flutter and 2 had atypical atrial flutter. The
ean  SD age and arrhythmia duration were 62  12
ears and 33  40 months, respectively. One (2.2%) patient
ad a previous pacemaker implant and implantable cardiac
efibrillator. The LVEF was 60% in 34 (75.6%) patients,
etween 35% and 60% in 7 (15.6%) patients, between 25%
nd 34% in 2 (4.4%) patients, and 25% in 1 (2.2%)
atient; LVEF data were unknown in 1 (2.2%) patient.
rocedure characteristics. There was no statistically sig-
ificant difference between acute success patients versus
cute failure patients in terms of the number of cryo tests
erformed (27  21 vs. 22  9) and cryoapplication time
44  22 min vs. 58  36 min) (Table 1). However, there
as a significant difference between these two groups in
erms of the number of cryo ablations delivered (9  13 vs.
4  31; p  0.032); almost four times as many cryo
blations were delivered to acute failure patients than acute
uccess patients (Table 1). As expected, procedure and
uoroscopy times were greater in acute failure patients than
cute success patients (Table 1).
There was no statistically significant difference between
onduction recurrent patients versus non-conduction recur-
ent patients in terms of the number of cryo tests performed
34  25 vs. 23  17) and cryoapplication time (44  22
able 1. Procedure Characteristics Associated With Particular G
Group
Cryo Tests
(Mean  SD;
Range)
Cryo
Ablatio
(Mean 
Rang
ll patients (n  45)* 27  20; 2–98 12  18;
atients who were acute successes
(n  39)*
27  21; 2–98 9  13;
atients who were acute failures
(n  6)
22  9; 15–28 34  31;
One patient had a pacemaker implant and implantable cardiac defibrillator.in vs. 43  22 min) (Table 2). However, there was a Eignificant difference between these two groups in terms of
he number of cryo ablations delivered (3  2 vs. 12  15;
 0.003); about four times as many cryo ablations were
elivered to non-conduction recurrent patients than con-
uction recurrent patients (Table 2). There were no marked
ifferences in procedure and fluoroscopy times between
onduction recurrent patients and non-conduction recurrent
atients (Table 2). Moreover, there were no major differ-
nces between these two groups in terms of patient charac-
eristics such as age, arrhythmia duration, and LVEF (Table
).
afety: acute and follow-up data. There were no reported
dverse events during or post ablation procedure before
ischarge from hospital (Table 3). There was no incidence
f cryo-induced permanent atrioventricular block. None
0%) of the 45 patients who were treated with cryo experi-
nced discomfort on cryo energy delivery. No adverse events
ere reported in any patient between hospital discharge and
ine-month follow-up, or at the repeat EPS.
fficacy: acute and follow-up data. The overall acute
uccess rate associated with this catheter was 87% (39 of 45
atients). There were 6 (13%) of 45 patients who were acute
ailures. Three-month repeat EPS data were available from
of Patients
Procedure
Time (min)
(Mean  SD;
Range)
Fluoroscopy
Time (min)
(Mean  SD;
Range)
Cryoapplication
Time (min)
(Mean  SD;
Range)
88  48; 20–250 24  10; 7–47 45  24; 10–101
77  36; 20–180 23  10; 7–47 44  22; 10–101
156  61; 70–250 29  9; 13–39 58  36; 10–94
able 2. Characteristics Associated With Acutely Successful
atients With and Without Conduction Recurrence
emonstrated on Repeat EPS at Three-Month Follow-up
Parameters
With
Conduction
Recurrence
(n  12)
Without
Conduction
Recurrence
(n  27)
ge (yrs) 57  13 66  10
rrhythmia duration (months) 33  37 34  42
VEF (n)
60% 11 20
35%–60% 1 3
25%–34% 0 2
25% 0 1
ryo tests, mean  SD; range 34  25; 4–98 23  17; 2–50
ryo ablations, mean  SD; range 3  2; 1–8 12  15; 1–73
ryoapplication time (min),
mean  SD; range
44  22; 16–98 43  22; 10–101
rocedure time (min),
mean  SD; range
79  41; 20–180 77  34; 25–144
luoroscopy time (min),
mean  SD; range
24  9; 9–36 23  11; 7–47roups
ns
SD;
e)
1–78
1–73
2–78PS  electrophysiologic study; LVEF  left ventricular ejection fraction.
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Atrial Flutter and Cryo Ablation February 15, 2005:573–809 acutely successful patients (Table 3). There was no
onduction recurrence demonstrated in 27 (69%) of 39
cutely successful patients. None (0%) of the 39 patients
howed symptom recurrence at three-month follow-up.
At six- and nine-month follow-up, data available from 39
cutely successful patients showed that all (100%) were
symptomatic, that is, symptom recurrence was not docu-
ented either by monthly Holter monitoring, ECG, and/or
atient diary records (Table 3).
ISCUSSION
o our knowledge, this is the first study that has reported on
he long-term efficacy of cryo ablation in a large number of
atients using both symptom recurrence and conduction
ecurrence as measured end points. Other cryo ablation
tudies have been limited by a combination of various
actors such as small sample size, a follow-up period of only
hree months or less, and assessment of long-term efficacy
y symptom recurrence alone (5,7,8). The strengths of the
urrent study are its reasonable sample size, a follow-up
eriod extending to nine months to assess symptom recur-
ence, and the performance of a repeat EPS at three months
ost intervention to assess conduction recurrence.
At intervention, bi-directional conduction block was
reated in 39 (87%) of 45 patients. However, three-month
ollow-up data showed that although all (100%) acutely
uccessful patients were asymptomatic, conduction recur-
ence was demonstrated in 12 (31%) patients on repeat
PS. Although six- and nine-month follow-up data showed
hat all (100%) acutely successful patients continued to be
able 3. Safety and Efficacy Outcomes Derived From
cutely Successful Patients at 3-, 6-, and
-Month Follow-up*
Parameters
3-Month
Follow-Up
6-Month
Follow-Up
9-Month
Follow-Up
atients without conduction
recurrence on repeat
EPS, n (%)
27 (69) — —
atients with conduction
recurrence on repeat
EPS, n (%)
12 (31) — —
atients without symptom
recurrence documented
by monthly Holter
monitoring, ECG,
and/or patient diary
records, n (%)
39 (100) 39 (100) 39 (100)
atients with symptom
recurrence documented
by monthly Holter
monitoring, ECG,
and/or patient diary
records, n (%)
0 (0) 0 (0) 0 (0)
dverse events reported 0 (0) 0 (0) 0 (0)
There were 39 acutely successful patients consenting to repeat EPS at three-month
ollow-up.
ECG  electrocardiogram; EPS  electrophysiologic study.symptomatic, three-month repeat EPS data suggest that rhere is a reservoir of asymptomatic patients who may
ventually become symptomatic. The six (13%) patients
ho were acute failures had on average almost four times
he number of ablations delivered (p  0.032), a longer
ryoapplication time, and over double the procedure time of
hose patients who experienced acute success with cryo at
ntervention (Table 1). The unsuccessful acute outcome in
ertain patients was primarily due to failure to localize and
blate the target site. However, the patient characteristics of
hose who were acute failures were not overtly different from
atients who were acute successes. Consequently, possible
redictors for failure at intervention could not be readily
dentified, although the procedure characteristics allude to
he difficulty of the ablation procedure in the acute failure
ases. Data concerning how many times a specific cryo test
ucceeded but subsequent ablation at the same site failed to
reate bi-directional block were not captured in this study;
nly data relating to the total number of cryo tests and
blations were captured for each patient. Analysis of various
lectrophysiologic and ablation characteristics associated
ith patients who were or were not recurrent on repeat EPS
lso failed to identify any strong predictors of conduction
ecurrence (Table 2), although patients without conduction
ecurrence had about four times as many cryo ablations
elivered during the procedure (p  0.003).
Cryo ablation has been shown to offer a number of
dvantages over other energy sources in terms of safety and
bsence of discomfort (7,8,13). Similarly, no adverse events
r patient discomfort with cryo energy delivery were re-
orted in the present study. This reflects an excellent safety
rofile for this new 7-F, 6-mm-tip catheter. In contrast,
ain has been reported to be experienced by patients with
trial flutter who were treated with RF ablation (13),
ossibly because the ablation site is highly innervated and
lose to the CS os. The use of cryo energy allowed ablation
round the CS os without causing pain in patients receiving
nly mild sedation.
The proof of bi-directional conduction block in the CTI
emains a critical issue in the confirmation of a successfully
blated atrial flutter. Although, the literature reports uni-
irectional or rate-dependent conduction block in more than
1% of the patient population treated with RF ablation (3,14),
his was not our experience with cryo. This suggests two
ossibilities. First, the area where we created lesions was more
ritical compared with the standard conventional isthmus
esion (7). Second, cryo energy produces a lesion more likely to
esult in bi-directional block. Each of these possibilities re-
uires further investigation. Despite nearly all patients (39 of
5 patients) being demonstrated to have bi-directional block at
he 30-min re-test, which followed the initial creation of
onduction block at intervention, conduction recurrence was
emonstrated in a number of asymptomatic patients consent-
ng to repeat EPS at three months. The ablation technique
erformed at intervention may explain why a number of these
symptomatic patients were later found to have conduction
ecurrence—the technique may have potentially left an anterior
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February 15, 2005:573–80 Atrial Flutter and Cryo Ablationap as the ablation started relatively posteriorly in the isthmus
elow the CS ostium. In addition, a longer period of cryo
nergy delivery at intervention,4 min, may have lessened the
onduction recurrence rate identified on repeat EPS post
rocedure. Our recent investigation of an 8-mm-tip catheter
sing an 8-min cryoapplication time to create permanent
i-directional block showed a 100% acute success rate, and
nly 2% of patients exhibited both conduction and symptom
ecurrence at three-month follow-up (15). This suggests that
lthough a 4-min cryoapplication time may be effective at
liminating conduction at the time of the 30-min re-test post
ntervention, this length of cryoapplication may not be maxi-
ally effective at creating permanent conduction block. More-
ver, a 30-min re-test periodmay not be a sufficient “wait time”
n which to ascertain that permanent conduction has been
reated. There may be a reservoir of cells in the cryo lesion that
re merely “stunned” and that will resume their arrhythmic
ctivity soon after the procedure. Ultimately, a longer cryoap-
lication time and a catheter powerful enough to create deeper
nd wider lesions may have yielded a higher acute success rate
nd less conduction recurrence post procedure than was ob-
erved in the present study.
tudy limitations. This study has limitations. First, the
tudy was not controlled. It was a single-arm study with no
andomized comparison to other smaller tipped cryo abla-
ion catheters or RF ablation catheters. Nonetheless, this
tudy ultimately sought to document our experience with a
ew 7-F, 6-mm cryo catheter for treatment of patients with
ymptomatic atrial flutter. Second, the study involved only
wo patients with atypical atrial flutter. Nonetheless, the 45
atients who were treated were representative of the general
opulation of symptomatic patients commonly referred to
xpert centers for ablation of atrial flutter. Third, an
natomic approach to ablation was partially used. This may
ave particularly compromised the ablation procedure in
atients who had atypical atrial flutter. This approach may
e improved by looking for a specific electrogram to help
dentify a suitable site for ablation. Fourth, measurement of
he conduction intervals across the isthmus before and
mmediately after cryo ablation and on repeat EPS to
ompare the intervals between patients who had complete
nd incomplete block would have been beneficial. Finally,
hree-month repeat EPS follow-up data were available from
9 patients, all of whom experienced acute success with
ryo. In a number of these patients, repeat EPS demon-
trated conduction recurrence even though all were asymp-
omatic. We postulate that perhaps a sufficient delay of
onduction remained at the isthmus that did not lead to
ymptom recurrence but could be identified as conduction
ecurrence. Although this disparity between conduction and
ymptom recurrence may allude to the possibility of there
eing a critical area for ablation to eradicate symptomatic
trial flutter, alternatively those asymptomatic patients who
ad conduction recurrence demonstrated on repeat EPS
ay ultimately be a reservoir of patients who will eventually
xperience symptom recurrence. Although six- and nine-onth data demonstrate that all acutely successful patients
ontinued to be asymptomatic, extended follow-up would
e useful to determine whether the symptom recurrence rate
ocumented by Holter monitoring, ECG, and/or patient
iary records eventually equals the conduction recurrence
ate identified by repeat EPS at three months post ablation.
ONCLUSIONS
his study documents our experience with a new 7-F, 6-mm
atheter for cryo ablation treatment of symptomatic atrial
utter. Neither adverse events nor discomfort with cryo energy
elivery were reported with the use of this catheter. No
ncidence of atrioventricular block occurred. Acute success,
efined as bi-directional isthmus block at intervention, was
chieved in 87% of treated patients. Three-month follow-up
ata available from 39 acutely successful patients showed that
ll (100%) patients were asymptomatic. Conduction recurrence
as demonstrated in 12 (31%) patients on repeat EPS at three
onths. Data available from 39 acutely successful patients at
ix- and nine-month clinical follow-up showed that all (100%)
atients remained asymptomatic. The results of this study add
o the growing list of studies that demonstrate cryo ablation
reatment of atrial flutter to be efficacious and safe. However,
urther monitoring is necessary to assess whether the absence of
ymptom recurrence observed at nine-month clinical follow-up
ontinues to be maintained over the long term.
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